Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 3/1998

Inhalt (6 Artikel)

ORIGINAL ARTICLE

Antitumor vaccination effect of dendritic cells can be augmented by locally utilizing Th1-type cytokines from OK432-reactive CD4+ T cells

Koji Tamada, M. Harada, Koichiro Abe, Tieli Li, Hitoshi Tada, Yasuhiro Onoe, Kikuo Nomoto

REVIEW

Tumour cell resistance to non-MHC-restricted lymphocytes: molecular mechanisms and clinical implications

P. Tagliaferri, Rosario Guarrasi, Michele Caraglia, Daniela Morelli, Antonietta Fabbrocini, Pierpaolo Correale, Angelo Raffaele Bianco

ORIGINAL ARTICLE

Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene

Z. Dong, Shin-Hun Juang, Rakesh Kumar, Ines Eue, Keping Xie, Diane Bielenberg, Weixin Lu, Corazon Bucana, Xiulan Yang, Isaiah J. Fidler

ORIGINAL ARTICLE

Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis

Yoshiaki Fujimiya, Youichi Suzuki, Ko-ichi Oshiman, Hidekazu Kobori, Koichi Moriguchi, Hisako Nakashima, Yonezo Matumoto, Shogo Takahara, Takusaburo Ebina, Ryuichi Katakura

ORIGINAL ARTICLE

Nitric oxide inhibits proliferation but increases life-span of T lymphocytes in tumour-bearing rats

Danièle Reisser, Patricia Lagadec, Laurent Arnould, Nathalie Onier, Véronique Maupoil, Dominique Pinard, Jean-François Jeannin

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.